Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated with Neoadjuvant Therapy in the GeparQuinto Trial

Background: Remodeling of extracellular matrix through collagen degradation is a crucial step in the metastatic cascade. The aim of this study was to evaluate the potential clinical relevance of the serum collagen degradation markers (CDM) C3M and C4M during neoadjuvant chemotherapy for breast cance...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancers (Basel)
Auteurs principaux: Banys-Paluchowski, Malgorzata, Loibl, Sibylle, Witzel, Isabell, Mundhenke, Christoph, Lederer, Bianca, Solbach, Christine, Karn, Thomas, Marmé, Frederik, Nekljudova, Valentina, Schem, Christian, Stickeler, Elmar, Willumsen, Nicholas, Karsdal, Morten A., Untch, Michael, Müller, Volkmar
Format: Artigo
Langue:Inglês
Publié: MDPI 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6721504/
https://ncbi.nlm.nih.gov/pubmed/31443252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11081186
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires